应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09966 康宁杰瑞制药-B
交易中 05-02 13:22:45
5.090
+0.340
+7.16%
最高
5.130
最低
4.650
成交量
63.88万
今开
4.700
昨收
4.750
日振幅
10.11%
总市值
49.11亿
流通市值
49.11亿
总股本
9.65亿
成交额
315.05万
换手率
0.07%
流通股本
9.65亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
康宁杰瑞制药-B盘中异动 股价大涨5.05%报4.990港元
自选股智能写手 · 11:01
康宁杰瑞制药-B盘中异动 股价大涨5.05%报4.990港元
康宁杰瑞制药-B(09966)根据限制性股份奖励计划授出合共13万股奖励股份
智通财经 · 04-23
康宁杰瑞制药-B(09966)根据限制性股份奖励计划授出合共13万股奖励股份
康宁杰瑞制药-B(09966.HK)授出118万份购股权
港股那点事 · 04-23
康宁杰瑞制药-B(09966.HK)授出118万份购股权
康宁杰瑞制药-B盘中异动 股价大涨5.28%报4.390港元
自选股智能写手 · 04-23
康宁杰瑞制药-B盘中异动 股价大涨5.28%报4.390港元
康宁杰瑞制药-B(09966)股价上升5.276%,现价港币$4.39
阿斯达克财经 · 04-23
康宁杰瑞制药-B(09966)股价上升5.276%,现价港币$4.39
康宁杰瑞制药-B盘中异动 急速下挫5.11%报4.100港元
自选股智能写手 · 04-19
康宁杰瑞制药-B盘中异动 急速下挫5.11%报4.100港元
康宁杰瑞制药-B(09966)股价下跌5.093%,现价港币$4.1
阿斯达克财经 · 04-19
康宁杰瑞制药-B(09966)股价下跌5.093%,现价港币$4.1
康宁杰瑞制药-B盘中异动 股价大跌5.09%报4.290港元
自选股智能写手 · 04-16
康宁杰瑞制药-B盘中异动 股价大跌5.09%报4.290港元
康宁杰瑞制药-B04月15日遭主力抛售78万元 环比增加143.75%
自选股智能写手 · 04-15
康宁杰瑞制药-B04月15日遭主力抛售78万元 环比增加143.75%
康宁杰瑞制药-B04月11日遭主力抛售103万元 环比增加194.29%
自选股智能写手 · 04-11
康宁杰瑞制药-B04月11日遭主力抛售103万元 环比增加194.29%
康宁杰瑞制药-B(09966.HK)治疗实体瘤药物临床研究显示初步抗肿瘤活性
阿斯达克财经 · 04-10
康宁杰瑞制药-B(09966.HK)治疗实体瘤药物临床研究显示初步抗肿瘤活性
【港股通】康宁杰瑞制药(09966)于AACR年会呈列JSKN003用于治疗晚期╱转移性实体瘤患者的I期临床研究的最新结果
金吾财讯 · 04-10
【港股通】康宁杰瑞制药(09966)于AACR年会呈列JSKN003用于治疗晚期╱转移性实体瘤患者的I期临床研究的最新结果
HER2双抗ADC药物JSKN003澳大利亚Ⅰ期临床研究数据亮相2024 AACR年会
美通社 · 04-10
HER2双抗ADC药物JSKN003澳大利亚Ⅰ期临床研究数据亮相2024 AACR年会
康宁杰瑞制药-B(09966)于2024年AACR年会呈列JSKN003用于治疗HER2表达晚期实体瘤的I期临床研究的最新结果
智通财经 · 04-10
康宁杰瑞制药-B(09966)于2024年AACR年会呈列JSKN003用于治疗HER2表达晚期实体瘤的I期临床研究的最新结果
康宁杰瑞制药-B04月09日主力资金流入155万元 连续3日加仓
自选股智能写手 · 04-09
康宁杰瑞制药-B04月09日主力资金流入155万元 连续3日加仓
康宁杰瑞制药-B(09966)股价显著上升11.98%,现价港币$4.58
阿斯达克财经 · 04-08
康宁杰瑞制药-B(09966)股价显著上升11.98%,现价港币$4.58
康宁杰瑞制药-B盘中异动 快速上涨5.13%报4.300港元
自选股智能写手 · 04-08
康宁杰瑞制药-B盘中异动 快速上涨5.13%报4.300港元
康宁杰瑞制药-B盘中异动 早盘快速下挫5.18%
自选股智能写手 · 04-05
康宁杰瑞制药-B盘中异动 早盘快速下挫5.18%
康宁杰瑞制药-B(09966)股价下跌5.376%,现价港币$4.4
阿斯达克财经 · 04-05
康宁杰瑞制药-B(09966)股价下跌5.376%,现价港币$4.4
港股异动 | 康宁杰瑞制药-B(09966)午后涨超7% 年内亏损同比收窄35.35% 产品收入增超32%
智通财经 · 04-03
港股异动 | 康宁杰瑞制药-B(09966)午后涨超7% 年内亏损同比收窄35.35% 产品收入增超32%
加载更多
公司概况
公司名称:
康宁杰瑞制药-B
所属市场:
SEHK
上市日期:
--
主营业务:
康宁杰瑞生物制药是一家投资控股公司,主要从事生物制药业务。公司专注于研发、生产和商业化创新肿瘤免疫生物大分子靶向药物的全产业链企业。公司拥有生物创新药开发技术平台,包括蛋白质工程平台、多功能抗体开发平台和抗体筛选平台。该公司在海内外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"09966","market":"HK","secType":"STK","nameCN":"康宁杰瑞制药-B","latestPrice":5.09,"timestamp":1714627336757,"preClose":4.75,"halted":0,"volume":638800,"delay":0,"floatShares":964843807,"shares":964843807,"eps":-0.23700775,"marketStatus":"交易中","marketStatusCode":2,"change":0.34,"latestTime":"05-02 13:22:45","open":4.7,"high":5.13,"low":4.65,"amount":3150538,"amplitude":0.101053,"askPrice":5.12,"askSize":7000,"bidPrice":5.08,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.2376667318140953,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1714637400000},"adr":0,"listingDate":1576080000000,"adjPreClose":4.75,"openAndCloseTimeList":[[1714613400000,1714622400000],[1714626000000,1714636800000]],"volumeRatio":0.701331,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09966","defaultTab":"news","newsList":[{"id":"2432697111","title":"康宁杰瑞制药-B盘中异动 股价大涨5.05%报4.990港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432697111","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432697111?lang=zh_cn&edition=full","pubTime":"2024-05-02 11:01","pubTimestamp":1714618901,"startTime":"0","endTime":"0","summary":"2024年05月02日早盘11时01分,康宁杰瑞制药-B股票出现波动,股价急速拉升5.05%。截至发稿,该股报4.990港元/股,成交量31.2万股,换手率0.03%,振幅7.16%。资金方面,该股资金流入108.784万港元,流出35.576万港元。康宁杰瑞制药-B股票所在的生物技术行业中,整体涨幅为0.90%。康宁杰瑞制药-B公司简介:康宁杰瑞生物制药是一家投资控股公司,主要从事生物制药业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405021101417925ab1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405021101417925ab1f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429952921","title":"康宁杰瑞制药-B(09966)根据限制性股份奖励计划授出合共13万股奖励股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2429952921","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429952921?lang=zh_cn&edition=full","pubTime":"2024-04-23 19:59","pubTimestamp":1713873577,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康宁杰瑞制药-B(09966)发布公告,于2024年4月23日,根据首次公开发售后购股权计划,公司已决议向四名合资格参与者(购股权承授人)(即集团的雇员)授出购股权,以认购最多合共118万股公司股本中每股面值0.000002美元的公司普通股,惟须待购股权承授人接纳后,方可作实。于授出日期,根据限制性股份奖励计划,公司已决议向两名合资格参与者授出合共13万股奖励股份,但须待奖励承授人接纳后,方可作实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107863.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429195701","title":"康宁杰瑞制药-B(09966.HK)授出118万份购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2429195701","media":"港股那点事","top":-1,"share":"https://www.laohu8.com/m/news/2429195701?lang=zh_cn&edition=full","pubTime":"2024-04-23 19:50","pubTimestamp":1713873000,"startTime":"0","endTime":"0","summary":"格隆汇4月23日丨康宁杰瑞制药-B公布,于2024年4月23日,根据首次公开发售后购股权计划,公司已决议向四名合资格参与者授出118万份购股权,授出购股权行使价每股4.350港元。公司认为,授出购股权及奖励股份为激励彼等为公司带来更高回报的重要激励措施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-23/doc-inasvrzs8692052.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-23/doc-inasvrzs8692052.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429515881","title":"康宁杰瑞制药-B盘中异动 股价大涨5.28%报4.390港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429515881","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429515881?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:28","pubTimestamp":1713850103,"startTime":"0","endTime":"0","summary":"2024年04月23日下午盘13时28分,康宁杰瑞制药-B股票出现波动,股价大幅拉升5.28%。截至发稿,该股报4.390港元/股,成交量120.6万股,换手率0.12%,振幅4.32%。资金方面,该股资金流入335.168万港元,流出137.299万港元。康宁杰瑞制药-B股票所在的生物技术行业中,整体涨幅为0.77%。康宁杰瑞制药-B公司简介:康宁杰瑞生物制药是一家投资控股公司,主要从事生物制药业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423132824861e8144&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423132824861e8144&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429884158","title":"康宁杰瑞制药-B(09966)股价上升5.276%,现价港币$4.39","url":"https://stock-news.laohu8.com/highlight/detail?id=2429884158","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429884158?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:28","pubTimestamp":1713850080,"startTime":"0","endTime":"0","summary":"[上升股]康宁杰瑞制药-B(09966) 股价在下午01:28比前收市价上升5.276%,现股价为港币$4.39。至目前为止,今日最高价为$4.39,而最低价为$4.21。总成交量为120.1万股,总成交金额为港币$512.291万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404232632/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2428577139","title":"康宁杰瑞制药-B盘中异动 急速下挫5.11%报4.100港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428577139","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428577139?lang=zh_cn&edition=full","pubTime":"2024-04-19 10:23","pubTimestamp":1713493413,"startTime":"0","endTime":"0","summary":"2024年04月19日早盘10时23分,康宁杰瑞制药-B股票出现波动,股价大幅下跌5.11%。截至发稿,该股报4.100港元/股,成交量98万股,换手率0.10%,振幅3.47%。资金方面,该股资金流入154.899万港元,流出179.562万港元。康宁杰瑞制药-B股票所在的生物技术行业中,整体跌幅为0.64%。康宁杰瑞制药-B公司简介:康宁杰瑞生物制药是一家投资控股公司,主要从事生物制药业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191023347921b312&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191023347921b312&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428577021","title":"康宁杰瑞制药-B(09966)股价下跌5.093%,现价港币$4.1","url":"https://stock-news.laohu8.com/highlight/detail?id=2428577021","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428577021?lang=zh_cn&edition=full","pubTime":"2024-04-19 10:23","pubTimestamp":1713493380,"startTime":"0","endTime":"0","summary":"[下跌股]康宁杰瑞制药-B(09966) 股价在上午10:23比前收市价下跌5.093%,现股价为港币$4.1。至目前为止,今日最高价为$4.25,而最低价为$4.1。总成交量为98万股,总成交金额为港币$407.627万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404192050/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2427811144","title":"康宁杰瑞制药-B盘中异动 股价大跌5.09%报4.290港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427811144","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427811144?lang=zh_cn&edition=full","pubTime":"2024-04-16 15:52","pubTimestamp":1713253937,"startTime":"0","endTime":"0","summary":"2024年04月16日临近收盘15时52分,康宁杰瑞制药-B股票出现波动,股价大幅下跌5.09%。截至发稿,该股报4.290港元/股,成交量182.8万股,换手率0.19%,振幅4.42%。资金方面,该股资金流入256.741万港元,流出445.605万港元。康宁杰瑞制药-B股票所在的生物技术行业中,整体跌幅为1.36%。康宁杰瑞制药-B公司简介:康宁杰瑞生物制药是一家投资控股公司,主要从事生物制药业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041615521787e80ee1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041615521787e80ee1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427250100","title":"康宁杰瑞制药-B04月15日遭主力抛售78万元 环比增加143.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427250100","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427250100?lang=zh_cn&edition=full","pubTime":"2024-04-15 16:17","pubTimestamp":1713169021,"startTime":"0","endTime":"0","summary":"04月15日, 康宁杰瑞制药-B股价跌1.95%,报收4.52元,成交金额851万元,换手率0.20%,振幅4.34%,量比0.74。康宁杰瑞制药-B今日主力资金净流出78万元,连续4日净流出,上一交易日主力净流出32万元,今日环比增加143.75%。该股近5个交易日下跌3.45%,主力资金累计净流出91万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入42万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415161733877e8fdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415161733877e8fdc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426990238","title":"康宁杰瑞制药-B04月11日遭主力抛售103万元 环比增加194.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426990238","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426990238?lang=zh_cn&edition=full","pubTime":"2024-04-11 16:16","pubTimestamp":1712823410,"startTime":"0","endTime":"0","summary":"04月11日, 康宁杰瑞制药-B股价跌2.73%,报收4.63元,成交金额789万元,换手率0.18%,振幅2.94%,量比0.57。康宁杰瑞制药-B今日主力资金净流出103万元,上一交易日主力净流出35万元,今日环比增加194.29%。该股近5个交易日上涨1.29%,主力资金累计净流入322万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入439万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111617138b0f29f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111617138b0f29f3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426170224","title":"康宁杰瑞制药-B(09966.HK)治疗实体瘤药物临床研究显示初步抗肿瘤活性","url":"https://stock-news.laohu8.com/highlight/detail?id=2426170224","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426170224?lang=zh_cn&edition=full","pubTime":"2024-04-10 09:02","pubTimestamp":1712710920,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B公布,JSKN003用于治疗晚期/转移性实体瘤患者的I期临床研究的研究结果,已在4月5至10日举行的2024年AACR年会上于壁报展示期间呈列。结论显示,JSKN003在既往经多线治疗的晚期/转移性实体瘤患者中耐受性和安全性良好,且显示出令人鼓舞的初步抗肿瘤活性。血液毒性和间质性肺疾病的发生率低。截至3月15日,所有入组患者均已完成剂量限制性毒性观察期,未发生DLT事件,最大耐受剂量尚未达到。沽空资料截至 2024-04-09 16:25。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20201218151510054_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20201218151510054_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1341137/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2426177652","title":"【港股通】康宁杰瑞制药(09966)于AACR年会呈列JSKN003用于治疗晚期╱转移性实体瘤患者的I期临床研究的最新结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2426177652","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2426177652?lang=zh_cn&edition=full","pubTime":"2024-04-10 08:48","pubTimestamp":1712710110,"startTime":"0","endTime":"0","summary":"金吾财讯 | 康宁杰瑞制药-B 宣布JSKN003用于治疗晚期╱转移性实体瘤患者的I期临床研究的研究结果已在2024年4月5日至2024年4月10日举行的2024年AACR年会上于壁报展示期间呈列。双表位HER2靶向性使JSKN003具有更强的内吞诱导及旁观者杀伤效应,使其在HER2表达肿瘤中具有较强的抗肿瘤活性。目前,JSKN003已在澳大利亚和中国分别开展I期和I/II期临床试验,并积极推进中国III期临床试验开展。","market":"hk","thumbnail":"https://static.szfiu.com/news/20200915/MTQ3MGYxNDE0OGI1OTUxMGM4OTJjZmIwYjlmNjI1MDU4NDg4OA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/MTQ3MGYxNDE0OGI1OTUxMGM4OTJjZmIwYjlmNjI1MDU4NDg4OA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1934732","is_publish_highlight":false,"gpt_icon":0},{"id":"2426617082","title":"HER2双抗ADC药物JSKN003澳大利亚Ⅰ期临床研究数据亮相2024 AACR年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2426617082","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2426617082?lang=zh_cn&edition=full","pubTime":"2024-04-10 08:41","pubTimestamp":1712709660,"startTime":"0","endTime":"0","summary":"本次AACR会议上报道的是JSKN003在剂量递增期(Ⅰa)的研究结果。JSKN003治疗HER2表达晚期/转移性实体瘤显示出令人鼓舞的疗效信号,HER2阳性乳腺癌患者ORR达到100%。中国苏州2024年4月10日 /美通社/ -- 康宁杰瑞生物制药宣布,公司在2024年美国癌症研究协会年会上,以壁报形式公布了HER2双抗偶联药物JSKN003在澳大利亚治疗HER2表达晚期实体瘤的Ⅰ期临床研究数据。目前JSKN003正在澳大利亚和中国开展多项临床研究,针对HER2低表达乳腺癌适应症已在国内进入Ⅲ期临床阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4383987_ZH83987_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426785451","title":"康宁杰瑞制药-B(09966)于2024年AACR年会呈列JSKN003用于治疗HER2表达晚期实体瘤的I期临床研究的最新结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2426785451","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426785451?lang=zh_cn&edition=full","pubTime":"2024-04-10 06:31","pubTimestamp":1712701901,"startTime":"0","endTime":"0","summary":"JSKN003用于治疗晚期╱转移性实体瘤患者的安全性及疗效结果结论:JSKN003在既往经多线治疗的晚期╱转移性实体瘤患者中耐受性和安全性良好,且显示出令人鼓舞的初步抗肿瘤活性。双表位HER2靶向性使JSKN003具有更强的内吞诱导及旁观者杀伤效应,使其在HER2表达肿瘤中具有较强的抗肿瘤活性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1100334.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426159674","title":"康宁杰瑞制药-B04月09日主力资金流入155万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2426159674","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426159674?lang=zh_cn&edition=full","pubTime":"2024-04-09 16:16","pubTimestamp":1712650607,"startTime":"0","endTime":"0","summary":"04月09日, 康宁杰瑞制药-B股价涨1.29%,报收4.70元,成交金额1182万元,换手率0.26%,振幅5.39%,量比0.77。康宁杰瑞制药-B今日主力资金净流入155万元,连续3日净流入,上一交易日主力净流入238万元,今日环比减少34.87%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为37.50%,平均涨幅为5.41%。该股近5个交易日上涨3.75%,主力资金累计净流入470万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流入526万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091617308758d613&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091617308758d613&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425560730","title":"康宁杰瑞制药-B(09966)股价显著上升11.98%,现价港币$4.58","url":"https://stock-news.laohu8.com/highlight/detail?id=2425560730","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2425560730?lang=zh_cn&edition=full","pubTime":"2024-04-08 09:55","pubTimestamp":1712541300,"startTime":"0","endTime":"0","summary":"[上升股]康宁杰瑞制药-B(09966) 股价在上午09:55比前收市价显著上升11.98%,现股价为港币$4.58。至目前为止,今日最高价为$4.58,而最低价为$4.27。总成交量为152.099万股,总成交金额为港币$676.509万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240408675/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2425604596","title":"康宁杰瑞制药-B盘中异动 快速上涨5.13%报4.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425604596","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425604596?lang=zh_cn&edition=full","pubTime":"2024-04-08 09:31","pubTimestamp":1712539909,"startTime":"0","endTime":"0","summary":"2024年04月08日早盘09时31分,康宁杰瑞制药-B股票出现波动,股价急速上涨5.13%。截至发稿,该股报4.300港元/股,成交量19.5994万股,换手率0.02%,振幅3.18%。康宁杰瑞制药-B股票所在的生物技术行业中,整体跌幅为0.01%。其相关个股中,康宁杰瑞制药-B、云顶新耀-B、泰格医药涨幅较大,振幅较大的相关个股有金斯瑞生物科技、创胜集团-B、康宁杰瑞制药-B,振幅分别为5.91%、3.70%、3.18%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408093149861e3a70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408093149861e3a70&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425303991","title":"康宁杰瑞制药-B盘中异动 早盘快速下挫5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425303991","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425303991?lang=zh_cn&edition=full","pubTime":"2024-04-05 10:22","pubTimestamp":1712283730,"startTime":"0","endTime":"0","summary":"2024年04月05日早盘10时22分,康宁杰瑞制药-B股票出现波动,股价快速下跌5.18%。截至发稿,该股报4.410港元/股,成交量1.8万股,换手率0.00%,振幅1.29%。康宁杰瑞制药-B股票所在的生物技术行业中,整体跌幅为1.24%。康宁杰瑞制药-B公司简介:康宁杰瑞生物制药是一家投资控股公司,主要从事生物制药业务。消息层面,截至10时22分,康宁杰瑞制药-B股票正面舆情新闻比例60%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404051022107a510d17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404051022107a510d17&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425307306","title":"康宁杰瑞制药-B(09966)股价下跌5.376%,现价港币$4.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2425307306","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2425307306?lang=zh_cn&edition=full","pubTime":"2024-04-05 10:22","pubTimestamp":1712283720,"startTime":"0","endTime":"0","summary":"[下跌股]康宁杰瑞制药-B(09966) 股价在上午10:22比前收市价下跌5.376%,现股价为港币$4.4。至目前为止,今日最高价为$4.47,而最低价为$4.4。总成交量为2000股,总成交金额为港币$8870。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404051504/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2424286587","title":"港股异动 | 康宁杰瑞制药-B(09966)午后涨超7% 年内亏损同比收窄35.35% 产品收入增超32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424286587","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2424286587?lang=zh_cn&edition=full","pubTime":"2024-04-03 14:35","pubTimestamp":1712126158,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,康宁杰瑞制药-B午后涨超7%,截至发稿,涨6.45%,报4.62港元,成交额1146.66万港元。消息面上,康宁杰瑞制药-B发布2023年度业绩,收入2.19亿元人民币,同比增长31.12%;年内亏损2.11亿元人民币,亏损同比收窄35.35%。公告称,收入增加主要来自四川思路康瑞药业有限公司。集团与思路迪医药于2016年2月就联合开发及商业化KN035订立许可协议。值得注意的是,今年1月24日,思路迪医药、康宁杰瑞将向Glenmark授予KN035肿瘤适应症的独家许可及再授权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1098344.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alphamab.com","stockEarnings":[{"period":"1week","weight":0.092},{"period":"1month","weight":0.0486},{"period":"3month","weight":0.2025},{"period":"6month","weight":-0.5926},{"period":"1year","weight":-0.6895},{"period":"ytd","weight":-0.2846}],"compareEarnings":[{"period":"1week","weight":0.0555},{"period":"1month","weight":0.0739},{"period":"3month","weight":0.1471},{"period":"6month","weight":0.0309},{"period":"1year","weight":-0.1071},{"period":"ytd","weight":0.042}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康宁杰瑞生物制药是一家投资控股公司,主要从事生物制药业务。公司专注于研发、生产和商业化创新肿瘤免疫生物大分子靶向药物的全产业链企业。公司拥有生物创新药开发技术平台,包括蛋白质工程平台、多功能抗体开发平台和抗体筛选平台。该公司在海内外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.131218},{"month":2,"riseRate":0.6,"avgChangeRate":0.11167},{"month":3,"riseRate":0,"avgChangeRate":-0.116679},{"month":4,"riseRate":1,"avgChangeRate":0.117691},{"month":5,"riseRate":0.5,"avgChangeRate":-0.00456},{"month":6,"riseRate":0.5,"avgChangeRate":0.047072},{"month":7,"riseRate":0.25,"avgChangeRate":-0.04775},{"month":8,"riseRate":0.25,"avgChangeRate":0.023258},{"month":9,"riseRate":0,"avgChangeRate":-0.110125},{"month":10,"riseRate":0.5,"avgChangeRate":0.045929},{"month":11,"riseRate":0.5,"avgChangeRate":0.076762},{"month":12,"riseRate":0.75,"avgChangeRate":0.015223}],"exchange":"SEHK","name":"康宁杰瑞制药-B","nameEN":"ALPHAMAB-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康宁杰瑞制药-B(09966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康宁杰瑞制药-B,09966,康宁杰瑞制药-B股票,康宁杰瑞制药-B股票老虎,康宁杰瑞制药-B股票老虎国际,康宁杰瑞制药-B行情,康宁杰瑞制药-B股票行情,康宁杰瑞制药-B股价,康宁杰瑞制药-B股市,康宁杰瑞制药-B股票价格,康宁杰瑞制药-B股票交易,康宁杰瑞制药-B股票购买,康宁杰瑞制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康宁杰瑞制药-B(09966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}